Abnormally Expressed lncRNAs as Potential Biomarkers for Gastric Cancer Risk: A Diagnostic Meta-Bioinformatics Analysis

Table 6

Diagnostic efficacy of the combined model for GC with different stages.

Stage	SEN	SPE	YI	Cut-off	AUC	(95% CI)		value
I	0.902	0.937	0.840	0.4114	0.947	(0.875-0.984)
II	0.929	0.938	0.866	0.5183	0.966	(0.922-0.989)	-0.703	0.482
III	0.973	0.938	0.910	0.4553	0.984	(0.952-0.997)	-1.504	0.133
IV	0.974	1	0.974	0.4548	0.998	(0.945-1.000)	-2.183	0.029
II+III+IV	0.953	0.938	0.891	0.6899	0.977	(0.955-0.991)	-1.192	0.233

value: -test testing AUC differences of GC different stages which all compared to stage I.